James Ford

Back to Profile

Publication Details

  • Intensity-modulated radiotherapy for pancreatic adenocarcinoma.

    Abelson JA, Murphy JD, Minn AY, Chung M, Fisher GA, Ford JM, Kunz P, Norton JA, Visser BC, Poultsides GA, Koong AC, Chang DT. Int J Radiat Oncol Biol Phys. 2012; 82 (4): e595-601

    To report the outcomes and toxicities in patients treated with intensity-modulated radiotherapy (IMRT) for pancreatic adenocarcinoma.

    PubMedID: 22197234

Stanford Medicine Resources:

Footer Links: